Sign in

CIK 0002079109 · <br>Emerging growth company

Veraxa Biotech AG - Post de-SPAC

Sign in to watch
Ticker
VRXA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
other
Phone
41443858450
Business address
TALACKER 35, ZURICH, Switzerland, 8001
Former names
Veraxa Biotech Holding AG

Securities

  • VRXA Ordinary Shares Nasdaq
  • VRXAW Warrants Nasdaq
  1. 6-K Event Report of Foreign Issuer
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 20-F Report Annual and Transition Report of Foreign Private Issuers
  6. SCHEDULE 13D Stake Beneficial Ownership Report
  7. SCHEDULE 13D Stake Beneficial Ownership Report
  8. SCHEDULE 13D Stake Beneficial Ownership Report
  9. SCHEDULE 13D Stake Beneficial Ownership Report
  10. 6-K Event Report of Foreign Issuer
  11. CERT Other Certification
  12. 8-A12B/A Other Registration Statement
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 8-A12B Other Registration of Securities

Page 2 of 3 · 56 filings